Answers are grounded in this paper and cite their sources.
Preclinical study reveals that tumor-intrinsic interferon-gamma signaling enables pioneer cell colonization in ovarian cancer, suggesting early seeds dictate metastatic success.
The mechanisms enabling disseminating tumor cells to survive and colonize peritoneal niches during ovarian cancer metastasis remain incompletely understood. Here, we present MetTag, a single-cell barcoding and transcriptome profiling approach with time-stamped batch identifiers to resolve temporal dynamics of dissemination. Sequencing of MetTag barcodes reveals enrichment of early-disseminated clones across metastatic sites, and targeted depletion of pioneers diminishes the outgrowth of later arriving cells. MetTag-coupled single-cell RNA sequencing uncovers a distinct interferon-gamma-centric transcriptional trajectory enriched among pioneer clones. CRISPR/Cas9 screening and subsequent interferon-gamma receptor 1 knockout in pioneer cells significantly reduces metastatic burden, highlighting a critical window where active interferon-gamma signaling shapes the post-seeding metastatic niche and outgrowth. Mechanistically, the tumor-intrinsic interferon-gamma response and peritoneal macrophages cooperatively shield disseminating tumor cells from anoikis. Our study defines the temporal clonal architecture of peritoneal metastasis, revealing a first come, first served dissemination principle, where pioneer fitness determines the success of subsequent colonizers. The mechanisms enabling disseminating tumour cells (DTCs) to survive and colonise peritoneal niches in ovarian cancer metastasis remain poorly understood. Using single-cell barcoding, transcriptome profiling, and in vivo CRISPR screening, the authors identify a niche-adaptive IFNγ response signature that supports pioneer DTC outgrowth.
No takes yet. Share an insight, caveat, or question.
Aleksandrovic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: